Related Experiment Videos

Differential risk of remission and ESRD in childhood FSGS

Debbie S Gipson1, Hyunsook Chin, Trevor P Presler

  • 1UNC Kidney Center, University of North Carolina, Chapel Hill, USA. Debbie_Gipson@med.unc.edu

Pediatric Nephrology (Berlin, Germany)
|January 6, 2006
PubMed

Insights

Achieving remission of proteinuria in children with Focal Segmental Glomerulosclerosis (FSGS) significantly improves long-term kidney survival. Complete or partial remission dramatically reduces the risk of end-stage renal disease (ESRD).

Area of Science:

  • Pediatric Nephrology
  • Glomerular Diseases
  • Renal Disease Progression

Background:

  • Focal segmental glomerulosclerosis (FSGS) is a primary cause of steroid-resistant nephrotic syndrome in children.
  • FSGS is a leading cause of end-stage renal disease (ESRD) stemming from glomerular disease in pediatric populations.
  • Understanding factors influencing FSGS progression is crucial for improving patient outcomes.

Purpose of the Study:

  • To assess the risk of disease progression in children with primary FSGS.
  • To evaluate the impact of proteinuria remission status on disease progression in pediatric FSGS.
  • To identify predictors of proteinuria remission and renal survival in this cohort.

Main Methods:

  • Retrospective cohort study of 60 children and adolescents with primary FSGS from the Glomerular Disease Collaborative Network.
  • Analysis of patient demographics, clinical characteristics (proteinuria, hypertension, eGFR), and treatment outcomes.
  • Multivariate analysis to determine predictors of proteinuria remission and renal survival.

Main Results:

  • Complete remission was achieved in 20%, partial remission in 33%, and 47% of patients.
  • Angiotensin-converting enzyme inhibitor (ACE-I)/angiotensin II receptor blocker (ARB) therapy was predictive of proteinuria remission (HR 3.35).
  • Complete remission was associated with a 90% decreased risk of ESRD (HR 0.10) in multivariate analysis.

Conclusions:

  • Proteinuria remission status is a significant predictor of long-term renal survival in children with FSGS.
  • Achieving complete or partial remission of proteinuria substantially improves renal survival.
  • ACE-I/ARB therapy may play a role in achieving proteinuria remission in pediatric FSGS.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...